Search Results - "Nakonechnikov, S N"

Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry by Chazova, I E, Valieva, Z S, Nakonechnikov, S N, Taran, I N, Martynyuk, T V

“…Aim: to perform the complex analysis of clinical, functional, hemodynamics profile in patients with inoperable chronic thromboembolic pulmonary hypertension…”
Get full text

The economic burden of chronic thromboembolic pulmonary hypertension in Russian Federation by Chazova, I E, Martynyuk, T V, Valieva, Z S, Nakonechnikov, S N, Nedogoda, S V, Salasyuk, A S, Taran, I N, Gratsianskaya, S E

“…The aim of current study was to estimate the economic burden of the chronic thromboembolic pulmonary hypertension (CTEPH) in Russia based on patient registry…”
Get full text

New horizons for the use of the second generation of endothelin receptor antagonist macitentan in patients with pulmonary hypertension by Martynyuk, T V, Nakonechnikov, S N, Chazova, I Ye

“…Since 2015, macitentan, the new oral dual endothelin receptors antagonist (ERA), has been successfully introduced into clinical practice in the Russian…”
Get full text

Clinical guidelines for the diagnosis and treatment of pulmonary hypertension by Chazova, I E, Avdeev, S N, Tsareva, N A, Volkov, A V, Martyniuk, T V, Nakonechnikov, S N

“…Pulmonary hypertension (PH) is a group of diseases characterized by progressive increases in pulmonary vascular resistance and pulmonary artery pressure, which…”
Get full text

Pulmonary hypertension in Russia: the first results of the national register by Chazova, I E, Arkhipova, O A, Valieva, Z S, Nakonechnikov, S N, Martyniuk, T V

“…To investigate the demographic and clinical characteristics of patients with pulmonary hypertension (PH) and chronic thromboembolic pulmonary hypertension…”
Get full text

Calculation of hemodynamics by the Fick method in pulmonary hypertension associated with congenital heart defects by Shmalts, A. A., Martynyuk, T. V., Nakonechnikov, S. N.

“…In December, 2021 at the IXth All-Russian Congress «Pulmonary Hypertension – 2021» the first Eurasian guidelines for the diagnosis and treatment of pulmonary…”
Get full text

Vasoreactivity testing in pulmonary hypertension associated with congenital heart disease by Shmalts, A. A., Gorbachevsky, S. V., Martynyuk, T. V., Nakonechnikov, S. N.

“…   In December, 2021 at the IXth All-Russian Congress «Pulmonary Hypertension 2021» the first Eurasian guidelines for the diagnosis and treatment of pulmonary…”
Get full text

ASPECTS OF MODERN COMBINATION SPECIFIC THERAPY OF PULMONARY ARTERIAL HYPERTENSION: THE PROS AND CONS by T. V. Martynyuk, S. N. Nakonechnikov, I. Ye. Chazova

“…The treatment algorithm for pulmonary arterial hypertension (PAH) includes three main stages: general measures; induction drug therapy; combined drug therapy…”
Get full text

Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension associated with congenital heart defects in adults (2021) by Chazova, I. E., Gorbachevskij, S. V., Martynyuk, T. V., Shmal’c, A. A., Valieva, Z. S., Baryshnikova, I. Yu, Glushko, L. A., Gramovich, V. V., Azizov, V. A., Veselova, T. N., Danilov, N. M., Zelveyan, P. A., Ivanov, S. N., Lazareva, I. V., Matchin, Yu. G., Mukarov, M. A., Nakonechnikov, S. N., Sarybaev, A. Sh, Stukalova, O. V., Shalaev, S. V.

Get full text

OPTIMIZATION OF SPECIFIC THERAPY FOR PULMONARY ARTERIAL HYPERTENSION: THE POSSIBILITIES OF USING ENDOTHELIN RECEPTOR ANTAGONISTS by Martynyuk, T. V., Nakonechnikov, S. N., Chazova, I. Ye

“…Modern concepts of pulmonary arterial hypertension (PAH) pathogenesis focus on the key role of endothelial dysfunction of pulmonary vessels. To control the…”
Get full text

MANAGEMENT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION IN THE PANDEMIC OF A NEW CORONAVIRUS INFECTION by Martynyuk, T. V., Aleevskaya, A. M., Rodnenkov, O. V., Zorin, A. V., Kasparova, A. M., Nakonechnikov, S. N., Chazova, I. E.

“…The pandemic of a new coronavirus infection – COVID-19 («Coronavirus disease 2019») has changed the routine management of patients with pulmonary arterial…”
Get full text

Risk of cardiovascular complications in patients with frequent hypertensive crises by Kolos, I P, Chazova, I E, Tereshchenko, S N, Nakonechnikov, S N

“…To investigate a relative risk of cardiovascular complications in uncomplicated hypertensive crises (UHC) in hypertensive patients. A questionnaire…”
Get full text

ORAL ANTICOAGULANTS IN PATIENTS WITH DIFFERENT FORMS OF PULMONARY ARTERIAL HYPERTENSION, ASPECTS OF THE PROBLEM by Gratsianskaya, S. Ye, Martynyuk, T. V., Nakonechnikov, S. N., Chazova, I. Ye

“…The use of direct oral anticoagulants in patients with pulmonary arterial hypertension (PAH) has remained a controversial issue for a decade. Despite the lack…”
Get full text

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (2020) by Chazova, I. E., Martynyuk, T. V., Valieva, Z. S., Azizov, V. A., Akchurin, R. S., Ansheles, A. A., Vasiltseva, O. Ya, Veselova, T. N., Galyavich, A. S., Gorbachevsky, S. V., Danilov, N. M., Edemskiy, A. G., Zelveyan, P. A., Lazareva, I. V., Matchin, Yu. G., Mershin, K. V., Mukarov, M. A., Nakonechnikov, S. N., Saidova, M. A., Sarybaev, A. Sh, Sergienko, V. B., Stukalova, O. V., Filippov, E. V., Chernyavsky, A. M., Chernyavsky, M. A., Shalaev, S. V., Shmalts, A. A.

“…Disclaimer The EAC Guidelines represent the views of the EAC, and were produced after careful consideration of the scientific and medical knowledge, and the…”
Get full text

ACCORDING TO THE RESULTS OF THE EUROPEAN CONGRESS OF CARDIOLOGY 2015: NEW VERSION OF GUIDELINES FOR DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION by Chazova, I. Ye, Martynyuk, T. V., Nakonechnikov, S. N.

Get full text

Quality of life in patients with idiopathic pulmonary hypertension: the first experience of trimetazidine by Kuznetsova, E G, Glukhova, S I, Martynyuk, T V, Nakonechnikov, S N, Chazova, I E

“…Objective - to estimate the quality of life with therapy of trimetazidine in patients with idiopathic pulmonary hypertension, I-III functional class. Material…”
Get full text

THE EFFICACY OF SILDENAFIL THERAPY IN PATIENTS WITH PULMONARY HYPERTENSION OF DIFFERENT ETIOLOGY: INFLUENCE ON THE CLINICAL, FUNCTIONAL, HEMODYNAMIC STATUS, STRUCTURE AND FUNCTION OF THE RIGHT AND LEFT HEART, RIGHT VENTRICULAR-ARTERIAL COUPLING by Martynyuk, T. V., Dadacheva, Z. H., Paramonov, V. M., Saidova, M. A., Nakonechnikov, S. N., Chazova, I. Ye

“…Aim: to study the efficacy of sildenafil therapy in pulmonary hypertension of different etiology, its influence on the clinical, functional, hemodynamic…”
Get full text

THE MODERN VIEW OF THE ADDITIONAL THERAPY, CORRECTING METABOLIC PARAMETERS IN PATIENTS WITH PULMONARY HYPERTENSION: TRIMETAZIDINE IN FOCUS by Valeeva, E. G., Martyniuk, T. V., Ivanov, K. P., Sergienko, V. B., Nakonechnikov, S. N., Chazova, I. Ye

“…SUMMERY According to the Russian data 34% of patients with pulmonary hypertension (PH) have complaints of chest pain. Currently, the cause of this symptoms can…”
Get full text

THE EFFECTIVENESS OF COMBINATION THERAPY WITH BOSENTAN AND SILDENAFIL IN PATIENTS WITH THE CLINICAL WORSENING OF IDIOPATHIC PULMONARY HYPERTENSION ON THE BACKGROUND OF SPECIFIC MONOTHERAPY by Paramonov, V. M., Martynyuk, T. V., Matchin, Yu. G., Masenco, V. P., Nakonechnikov, S. N., Chazova, I. Ye

“…SUMMERY Objective: to evaluate the combination therapy efficacy and safety of bosentan and sildenafil in patients with idiopathic pulmonary hypertension (IPAH)…”
Get full text

INNOVATION IN PHARMACEUTICAL TREATMENT OF PULMONARY ARTERIAL HYPERTENSION: STIMULATOR OF SOLUBLE GYANYLATE CYCLASE - RIOCIGUAT by Taran, I. N., Martynyuk, T. V., Nakonechnikov, S. N., Chazova, I. Ye

“…Pulmonary arterial hypertension (PAH) is a rare disease, diagnosed at a late stage with low functional class III or IV (WHO). PAH leads to severe right heart…”
Get full text